Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
Authors: Bakkum-Gamez JN,  Wentzensen N,  Maurer MJ,  Hawthorne KM,  Voss JS,  Kroneman TN,  Famuyide AO,  Clayton AC,  Halling KC,  Kerr SE,  Cliby WA,  Dowdy SC,  Kipp BR,  Mariani A,  Oberg AL,  Podratz KC,  Shridhar V,  Sherman ME
Journal: Gynecol Oncol
Date: 2015 Apr
Branches: HREB
PubMed ID: 25677060
PMC ID: PMC4380654
Abstract: OBJECTIVE: We demonstrate the feasibility of detecting EC by combining minimally-invasive specimen collection techniques with sensitive molecular testing. METHODS: Prior to hysterectomy for EC or benign indications, women collected vaginal pool samples with intravaginal tampons and underwent endometrial brushing. Specimens underwent pyrosequencing for DNA methylation of genes reported to be hypermethylated in gynecologic cancers and recently identified markers discovered by profiling over 200 ECs. Methylation was evaluated individually across CpGs and averaged across genes. Differences between EC and benign endometrium (BE) were assessed using two-sample t-tests and area under the curve (AUC). RESULTS: Thirty-eight ECs and 28 BEs were included. We evaluated 97 CpGs within 12 genes, including previously reported markers (RASSF1, HSP2A, HOXA9, CDH13, HAAO, and GTF2A1) and those identified in discovery work (ASCL2, HTR1B, NPY, HS3ST2, MME, ADCYAP1, and additional CDH13 CpG sites). Mean methylation was higher in tampon specimens from EC v. BE for 9 of 12 genes (ADCYAP1, ASCL2, CDH13, HS3ST2, HTR1B, MME, HAAO, HOXA9, and RASSF1) (all p<0.05). Among these genes, relative hypermethylation was observed in EC v. BE across CpGs. Endometrial brush and tampon results were similar. Within tampon specimens, AUC was highest for HTR1B (0.82), RASSF1 (0.75), and HOXA9 (0.74). This is the first report of HOXA9 hypermethylation in EC. CONCLUSION: DNA hypermethylation in EC tissues can also be identified in vaginal pool DNA collected via intravaginal tampon. Identification of additional EC biomarkers and refined collection methods are needed to develop an early detection tool for EC.